NeuroStar TMS
A new possibility in treating depression
NeuroStar uses focused magnetic pulses (similar in strength to an MRI), to revitalize underactive areas of the brain involved in regulating
mood. When these regions are underactive, depression can result. “Waking up” these regions can have a lasting effect on depression,
making long-term remission from depression a reality for many people.
Treatment with NeuroStar Advanced Therapy is easy:
• Therapy sessions are conducted in your NeuroStar doctor’s office
• You can return to normal activities right away
• You are awake during treatment
• There are no negative effects on memory or sleep
• It’s covered by most health insurance plans, including Medicare and Tricare
Patient Health Questionnaire- Assess Your Depression
Scan to access a short list of questions used by your provider to assess the severity of depression. Your answers will be securely transmitted to your provider to review during your appointment. You may also access the questionnaire HERE.
NeuroStar TMS Treatment
A Safe, Proven Option for Depression
Does it work?
For people who have not found relief with antidepressants, NeuroStar is a safe and proven depression treatment without the systemic
side effects of medication. Over 4.8 million NeuroStar Advanced TMS treatments have been performed in over 134,000 patients.
Does it hurt?
Many patients experience side effects from their medication, increasing the chance that they will stop taking them. The most common
side effect with NeuroStar is mild to moderate pain or discomfort at the treatment site. For most patients this subsides within the first
week of treatment.
Is it covered?
NeuroStar TMS is covered by most major insurance providers, including Medicare plans nationwide. Our office will work with you to verify your benefits and help navigate the approval process so you can focus on your treatment and recovery.
What To Expect
What you can expect from a NeuroStar Advanced Therapy (TMS) session:
Before Treatment
You’ll recline comfortably in the treatment chair. A curved magnetic coil will be positioned on your head.
During Treatment
You’ll hear a clicking sound and feel a tapping sensation on your head as the NeuroStar coil focuses treatment precisely at the source of the depression: the brain. The patented Contact Sensing technology ensures the prescribed dose is delivered, every treatment, every pulse.
After Treatment
With NeuroStar TMS you are fully awake and alert during treatment and may drive home and resume daily activities immediately afterwards. Depending on your doctor’s recommendation, a typical NeuroStar treatment plan includes 36 sessions that each last between 19-37 minutes. Completing the full NeuroStar treatment course gives the best chance for delivering long-lasting relief from depression.
Frequently Asked Questions
Everything You Need to Know About NeuroStar TMS
NeuroStar TMS is a non-drug, noninvasive treatment that uses focused magnetic fields to revitalize underactive areas of the brain
to improve symptoms of depression. NeuroStar is a safe, effective depression treatment for people who have not found relief from
antidepressants.
NeuroStar uses focused magnetic pulses (similar in strength to an MRI), to revitalize underactive areas of the brain involved in regulating
mood. When these regions are underactive, depression can result. “Waking up” these regions can have a lasting effect on depression,
making long-term remission from depression a reality for many people.
A typical NeuroStar treatment plan includes 36 sessions that each last between 19-37 minutes. Your doctor will determine what is right
for you. Completing the full NeuroStar treatment course gives the best chance for delivering long-lasting relief from depression.
NeuroStar is covered by most major insurance plans, including Medicare and Tricare. Over 300 million people have insurance plans that
cover NeuroStar.
NeuroStar is a safe and effective treatment without the systemic side effects of medication. The most common side effect is mild to
moderate pain or discomfort at the treatment site. For most patients this subsides within the first week of treatment.
No. TMS Therapy involves a unique method of using pulsed magnetic fields for a therapeutic benefit. The intensity of the magnetic field
is similar to that of an MRI. These techniques differ radically from the popular use of low intensity, static magnetic fields. Those products
deliver weak and undirected static fields that are not capable of activating brain cells. The activation and stimulation of brain cells is a
key part of why TMS is so effective.
INDICATION STATEMENT
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy system is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
CLINICAL & ACADEMIC REFERENCES
Carpenter LL, et al. (2012). Transcranial Magnetic Stimulation (TMS) for Major Depression: A Multisite, Naturalistic, Observational Study of Acute Treatment Outcomes in Clinical Practice. Depression and Anxiety, 29(7):587-596. www.ncbi.nlm.nih.gov/pubmed/22689344
George MS, et al. (2010). Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder: A Sham-Controlled Randomized Trial. Arch Gen Psychiatry, 67(5):507-516. www.ncbi.nlm.nih.gov/pubmed/20439832
Dunner DL, et al. (2014). A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation (TMS) for Patients with Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period. J Clin Psychiatry. 75(12):1394-1401. www.ncbi.nlm.nih.gov/pubmed/25271871
O’Reardon JP, et al. (2007). Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial. Biol Psychiatry, 62(11):1208-1216. www.ncbi.nlm.nih.gov/pubmed/17573044
